RANDAL J KIRK Insider Trading $SYN Synthetic Biologics, Inc.
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).
RANDAL J KIRK in Synthetic Biologics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 92,159 shares
Current Value: $78,335
Latest Transaction: Apr 03 2019
$SYN Market Capitalization: $76.50M
$SYN Previous Close: $0.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RANDAL J KIRK in Synthetic Biologics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.65 | 69,161 | 44,955 | 165,332 | 234.5 K to 165.3 K (-29.49 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.65 | 26,080 | 16,952 | 62,342 | 88.4 K to 62.3 K (-29.49 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.66 | 9,909 | 6,540 | 234,493 | 244.4 K to 234.5 K (-4.05 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.66 | 3,737 | 2,466 | 88,422 | 92.2 K to 88.4 K (-4.05 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.67 | 30,265 | 20,278 | 244,402 | 274.7 K to 244.4 K (-11.02 %) |
| Apr 03 2019 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.67 | 11,413 | 7,647 | 92,159 | 103.6 K to 92.2 K (-11.02 %) |
| Sep 04 2015 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Buy | P | 3.20 | 937,500 | 3,000,000 | 9,613,268 | 8.7 M to 9.6 M (+10.81 %) |
Page: 1